Abstract-Underlying a cancer phenotype is a specific gene regulatory network that represents the complex regulatory relationships between genes. It remains, however, a challenge to find cancer-related gene regulatory network because of insufficient sample sizes and complex regulatory mechanisms in which gene is influenced by not only other genes but also other biological factors. With the development of high-throughput technologies and the unprecedented wealth of multi-omics data it gives us a new opportunity to design machine learning method to investigate underlying gene regulatory network. In this paper, we propose an approach, which use Biweight Midcorrelation to measure the correlation between factors and make use of Nonconvex Penalty based sparse regression for Gene Regulatory Network inference (BMNPGRN). BMNCGRN incorporates multi-omics data (including DNA methylation and copy number variation) and their interactions in gene regulatory network model. The experimental results on synthetic datasets show that BMNPGRN outperforms popular and state-of-the-art methods (including DCGRN, ARACNE, and CLR) under false positive control. Furthermore, we applied BMNPGRN on breast cancer (BRCA) data from The Cancer Genome Atlas database and provided gene regulatory network.
measures is the Pearson correlation measure [9] , 10]. Meanwhile, gene co-expression network analysis is one of the most important gene regulatory network analyses. Weighted gene co-expression network analysis (WGCNA) is a representative method of the correlation-based methods [11] . For different characteristics of data, methods which based on different correlation coefficients were proposed. For example, mutual information-based gene network analysis, maximum information correlation-based gene network analysis, cosine similarity-based gene network analysis, spearman rank correlation-based gene network analysis and conditional mutual information-based gene network analysis. Compared with the gene co-expression network analysis, gene differential co-expression analysis based on correlation measure can discover tiny but important biomolecule changes through identifying subtle changes in gene expression levels from case-control group [12] . For example, gene regulatory network analysis based on GO term and identifying differentially co-expression genes and links from gene expression microarray data (DCGL) outperforms than WGCNA in terms of sensitivity and specificity and real data sets result. However, the relationship between genes is still unclear due to gene interactions are mediated by other biological factors. Meanwhile, correlation measurement-based method use an undirected graph, which cannot explain the regulatory relationship between genes [7] , [13] , [14] .
Bayesian-based methods make it possible to infer the regulatory relationship of genes based on the directed acyclic graph (DAG) [15] . Many studies reported directed gene regulation graphs [16] . With the development of Bayesian network, dynamic Bayesian network was used to model time varying gene regulatory network. Moreover, Bayesianbased methods can deal with data missing problem and noise [17] . Bayesian-based methods can also efficiently incorporate prior biological knowledge such as structural information in the model [16] . However, those Bayesianbased methods are not suitable for large-scale biological data sets because its runtime will increase exponentially as the number of genes increases [18] , [19] , [20] .
Regression-based methods decomposes the complex gene regulatory network problem into P (number of genes) regression problems. In practice, regression-based methods need to solve small sample size and high-dimensional problems, thus regression-based gene regulatory network inference models contain regularization and are sparse models. Regularization regression models have often adapted LASSO for selecting significant network-related biological factors (e.g., genes, DNA methylation sites, CNVs) [21] . Regularization regression models can ensure efficiency even with large-scale biological data sets. Meanwhile, Regularization regression models are high-ranking methods in the HPN-DREAM network inference challenge. Recently, several regression-based researches focus on finding gene regulatory network by combining heterogeneous data [22] . Experimental results on synthetic data and real data show that methods can improve the accuracy of gene regulatory network inference by combining a variety of biological factor information [23] , [24] . DCGRN (DNA methylation and CNV Gene Regulatory Network) is a representative method of the regularization regression models [22] . DCGRN proposed an integrative gene regulatory network inference method by using gene expression, DNA methylation and CNV [22] . Such method assumes the number of gene-related DNA methylation is one [25] . However, biological experiments have shown that multiple methylation sites affect one gene [26] . A function module formed by the interaction of multiple methylation sites affects gene expression. [22] have applied LASSO to select biological factors of gene regulatory network. LASSO may not be applied directly to multi-omics data since LASSO ignores prior information present in wealth of multi-omics data. In addition, although the LASSO achieved good results [21] , [22] , L1-regularization is a convex relaxation formulation of L0-regularization. L1-regularization often leads to suboptimal solution because it is not a good approximation to L0-regularization. Nonconvex penalty functions such SCAD (Smoothly Clipped Absolute Deviation) [27] and MCP (Minimax Concave Penalty) [28] were applied to sparse problems and achieved better performance than traditional methods.
In this paper, we propose an approach, which use Biweight Midcorrelation to measure the correlation between factors and make use of Nonconvex Penalty based sparse regression for Gene Regulatory Network inference (BMNPGRN). BMNPGRN integrates heterogeneous multi-omics data to infer gene regulatory network with gene expression data, DNA methylation data and copy number variation data. In order to infer gene regulatory network. Firstly, we combine biweight midcorrelation coefficient algorithm, which is an efficient algorithm for computing correlation coefficient, with 'differential correlation strategy' to learn associations among DNA methylation sites. Then, nonconvex penalty based sparse regression is used to find gene-related biological factors, and the parameter of method is determined by cross-validation. Meanwhile, nonconvex penalty based sparse regression is used under stability selection which can control false positives effectively [29] . Finally, BMNPGRN identifies gene regulatory network based on the probabilities of biological factors (i.e., gene, DNA methylation sites, and CNV).
Our proposed approach BMNPGRN has advantages over existing gene regulatory network inference methods. Firstly, BMNPGRN can find more DNA methylation sites which are associated with gene regulatory network. Such method provide deeper insight into gene regulation mechanism. Secondly, BMNPGRN can effectively control false positives using stability selection strategy. Furthermore, BMNPGRN can more accurately find biological factors using nonconvex penalty based sparse regression. Finally, to the best of our knowledge, BMNPGRN is the first method which is applied to breast cancer data obtained by highthroughput sequencing technology.
In our experiments, we first compared the receiver operating characteristic (ROC) performance of BMNPGRN with well-known gene regulatory network inference methods (DCGRN, ARACNE and CLR) [22] , [30] , [31] in two kinds of synthetic data sets, experiment results show that BMNPGRN can significantly improve the performance of detecting gene regulatory network under false positive control. The mean and variance of AUC values obtained from multiple experiment results show that the stability of BMNPGRN is better than state-of-the-art methods of biological network inference. We then applied BMNPGRN on breast cancer data from The Cancer Genome Atlas (TCGA) database and identified several cancer-related gene regulatory network.
METHODS
Before introducing our method, we summarize the notations used in this article. Matrices are denoted by boldface uppercase, vectors are denoted by boldface lowercase, and scalars are denoted by lowercase letters. We denote the gene expression matrix by X 2 R NÂP , N represents number of samples and P represents number of genes, x j represents the jth column of gene expression matrix, x i represents the ith row of gene expression matrix, and x i j represents the (i, j) entry of matrix. Meanwhile, DNA methylation matrix is denoted by D 2 R NÂQ with N samples and Q DNA methylation sites, and copy number variation matrix is denoted by C 2 R NÂP with P CNVs. We show how to discover gene regulatory network, next. In brief, we first present a new scheme to find gene-related DNA methylation sites and, then, select significant gene regulation-related biological factors (including genes, DNA methylation sites) using nonconvex penalty based sparse regression. In addition, we use nonconvex penalty based sparse regression under stability selection which can control false positives effectively.
A New Scheme to Find Gene-Related Dna Methylation Sites
Given the datasets containing gene expression data, copy number variation data, and DNA methylation data, we use the heterogeneous multi-omics data to infer gene regulatory network. In general, a dataset include both patient and normal samples. The correlation coefficient of functionally related DNA methylation sites varies greatly from normal sample to patient sample. Based on the characteristics of biological data, we propose a new scheme to find generelated DNA methylation sites. First we need to calculate the correlation coefficient between expression vectors of DNA methylation sites. Researchers have proposed many methods to measure the correlation coefficient between two variables. Pearson correlation coefficient is a representative method of correlation coefficient approaches [9] , [10] . However, Pearson correlation coefficient is sensitive to outliers. Biweight midcorrelation is considered to be a good alternative to Pearson correlation coefficient since it is more robust to outliers. To calculate correlation coefficient between DNA methylation sites, we use biweight midcorrelation, which shall be described in the next section. On the basis of correlation coefficients from patient samples and normal samples, we adopt a differential correlation strategy. This strategy is similar to the case-control sample correlation coefficient measurement step followed by threshold-based variables selection [32] , [33] , [34] .
Biweight Midcorrelation Coefficient
In order to introduce the biweight midcorrelation coefficient (BIMC) of two numeric vectors x ¼ ðx 1 ; . . . ; x n Þ and y ¼ ðy 1 ; . . . ; y n Þ, x and y can be two column vectors of DNA methylation matrix (see Fig. 1 ), u i , v i are defined with i ¼ 1; . . . ; n as follows:
where medðxÞ and medðyÞ are the median of vector x and y respectively. madðÁÞ represents the median absolute deviation of numeric vector. Based on u i and v i . The weights w ðxÞ i for x i and w ðyÞ i for y i are defined as follows: w
where I is an indicator equation, for equation (5), the indicator equation Ið1 À jv i jÞ is 1 if ð1 À jv i jÞ > 0 and otherwise equals to 0. The same situation occurs for equation (4) . For equations (2) and (5), as the difference between y i and medðyÞ gets smaller and smaller, w ðyÞ i gets closer to 1. If the difference between y i and medðyÞ is larger than T Á madðyÞ, w ðyÞ i equals to 0. The same situation occurs for equations (1) and (4) . T is a pre-defined parameter. Let us discuss predefined parameter T . In practice, T is chosen between 5 and 9; the bigger T , the smaller the number of values to be filtered out. In this article, T is set to 9. For T , we chose the highest valid value to include all potentially interesting values. In addition, users can determine T based on the data characteristics and possible proportion of outliers. The weight values of all outliers are guaranteed to be 0. Based on w ðxÞ i and w ðyÞ i , we can define BIMC of vector x and y as follows:
where BIMCðx; yÞ represents the BIMC of x and . . . It should be noted that, the range of BIMC is from -1 to 1. If there is a strong positive linear relationship between DNA methylation vectors, the value of BIMC will be close to 1. If there is a strong negative linear relationship between methylation vectors, the value of BIMC will be close to -1. If there is no linear relationship or only a weak linear relationship between methylation vectors, the value of BIMC will be 0 or close to 0. In order to explain how to use biweight midcorrelation to calculate the correlation coefficient of DNA methylation sites. Let us take DNA methylation matrix as an example. Example of a DNA methylation matrix is shown in Fig. 1 .
For each sample S i , we measure level of expression at each DNA methylation site, d i j represents the expression level of the j-th DNA methylation site for the ith sample where j ¼ 1; . . . ; q. The ith column vector of DNA methylation matrix is expression level of ith DNA methylation site (DMsi). Then we can use the first and second column vectors of the matrix to calculate the correlation coefficient between DMs1 and DMs2.
In this study, the absolute value of the BIMC of DNA methylation sites in the same function module approaches to be 1. The stronger the association, the larger the BIMC value of the DNA methylation sites. In order to find DNA methylation sites that are strongly associated with a specific DNA methylation site, we use BIMC with 'differential correlation strategy', which shall be described in the next section.
Differential Correlation Strategy
Reasonable use of data characteristics can provide effective prior information. According to the existing relevant biological research results, the value of a methylation site in patient sample differs from that in the control sample; at the same time, the association between methylation sites in the patient sample differs from that in the control sample. In addition, DNA methylation sites are often located in core sequences of gene promoters and transcription start sites (TSS) [35] , and they often affect the nearest gene [36] . This prior information helps us find important DNA methylation sites for specific genes. In this section, we introduce 'differential correlation strategy'. This strategy is used to find gene-related DNA methylation sites using two different label samples (disease label samples and normal label samples). This strategy is similar to the gene differential co-expression analysis which find biological pathways or gene function module through measuring gene correlation changes between patient samples and control samples [32] , [33] , [34] .
Firstly, for a specific gene G, we determine the corresponding DNA methylation site DMs G at the promoter or transcription start sit of the gene G by searching relevant public database (e.g., MethDB: http://www.methdb.de/). Secondly, we calculate the BIMCs between DNA methylation site DMs G and all other DNA methylation sites in the patient samples and control samples, respectively. BIMC dmps ¼ ½a 1 ; a 2 ; . . . ; a qÀ1 represents BIMCs between DMs G and all other DNA methylation sites in the patient samples, and vector BIMC dmcs ¼ ½b 1 ; b 2 ; . . . ; b qÀ1 represents BIMCs between DMs G and all other DNA methylation sites in the control samples. For the two elements of the same position in two vectors BIMC dmps and BIMC dmcs (e.g., a 1 and b 1 ), the two values are calculated from the same pair of DNA methylation sites. Thirdly, in order to find differential correlation methylation sites, we set two thresholds TS 1 and TS 2 ; vector BIMC dmpc ¼ ½e 1 ; e 2 ; Á Á Á ; e qÀ1 contains only 0 and 1 (0 for no correlation and 1 for correlation) indicates whether methylation site is related to the DMs G . If absolute value of BIMC dmps ðiÞ is less than or equal to TS 1 and absolute value of BIMC dmcs ðiÞ is larger than or equal to TS 2 , BIMC dmpc ðiÞ is set to 1; if BIMC dmps ðiÞ is larger than or equal 
BMNPGRN Model
Our proposed method BMNPGRN is used to discover a directed network that encodes the regulatory relationships over a set of genes and selected methylation sits, these selected methylation sites were obtained by applying biweight midcorrelation coefficient and differential correlation strategy to the raw data. And we focus on the impact of CNV on the gene which in the region of CNV. Let X 2 R NÂP denotes gene expression matrix of N samples and P selected genes. D 2 R NÂQ S denotes DNA methylation matrix of N samples and Q S DNA methylation sites, C 2 R NÂP denotes copy number variation matrix of N samples and P CNVs. The three data matrices are defined as X ¼ ½x 1 ; x 2 ; . . . ; x p , D ¼ ½d 1 ; d 2 ; . . . ; d q s , and C ¼ ½c 1 ; c 2 ; . . . ; c p where x i ; d i ; c i are ith column vector of X; D and C respectively. Gene expression vector affected by biological factors is defined as follows:
where f i and w i are ith column vector of adjacency matrix F 2 R P ÂP and W 2 R P ÂP respectively; g i is sub-vector of ith column vector of adjacency matrix G 2 R QÂQ , the number of elements in the g i is Q S , the other elements of the ith column vector in adjacency matrix G 2 R QÂQ are 0. u i is a model bias and " i is a residual. f ij represents the regulation modes from ith gene to jth gene: positive for activation, negative for repression, and 0 for no regulation. In this study, we focus on the regulation relationship among genes, thus there is no self-regulation and every diagonal element f ii ¼ 0. Meanwhile, there is no two nodes cycle (i.e., both f ij and f ji are non-zero) in BMNPGRN. In addition, it is assumed that a gene can be directly affected by methylation site belong to the gene and other DNA methylation sites that are highly correlated with the methylation site. And a gene can be directly affected by CNV that belong to the gene but no other CNVs. g ij and w ii represent the regulation weight value of DNA methylation site and CNV of ith gene. For equation (8) , we want to find F, G and W that can best represent weights of genes, DNA methylation sites and CNVs. Our goal is to estimate f i ; g i , and w i that minimize " i , after the bias is removed by mean centering, equation (8) can be restated as follows:
where k Á k 2 denotes L2-norm. Generally speaking, L1-norm penalty is often used to avoid overfitting and accurately find genes, DNA methylation sites and CNVs that influence ith gene. L1-norm penalty is applied to all columns of F, G and W, then equation (9) based on the L1-regularization can be expressed as follows:
where 1 ; 2 and 3 are hyper-parameters for sparsity regularization. Equation (10) can be rewritten as follows: 
for ! ¼ 0 and g > 1. SCAD is defined on ½0; 1Þ by:
for !¼ 0 and g > 2. The above LASSO problem (i.e., equation (11)) can be restated as follows:
where P þ Q S represents the sum of genes, selected DNA methylation sites and CNV. Solving equation (16) depends on the choice of the tuning parameters and g. This is usually accomplished with cross-validation strategy. However, if only cross-validation is used, we often obtain many false positives (i.e., true zero weights are non-zero in estimated weight vector b i ). In order to effectively control false positives and find more truly related genes and DNA methylation sites. We augment equation (16) with stability selection [29] to determine edges in gene regulatory network. Stability selection strategy is a bootstrapping-type algorithm which can effectively control false positives. Briefly, stability selection strategy works as follows: Firstly, we randomly select half (i.e., bN=2c) of the total samples for T ss times. Secondly, for each selected subsamples, equation (16) is run on the samples. Finally, stability selection strategy select factors (i.e., genes, DNA methylation sites and copy number variation) whose weight values are non-zero for T ss Á z ts times, where z ts is a user-defined parameters.
We discuss how to determine user-defined parameters T ss and z ts , next. In practices, a large number of experimental results show that T ss ! 100 is sufficient to achieve false positive control [29] . Meanwhile, z ts is often chosen between 0.5 and 1; in theory, under certain conditions, [29] gives the relationship between the number of false positives and z ts . When finding edges between genes, DNA methylation sites, copy number variation and the ith genes,
where EðV i Þ is the expected number of falsely detected factors (i.e., genes, DNA methylation sites and copy number variation) for the ith gene. l 2 Ã ;g Ã is the number of non-zero weights found by BMNPGRN with Ã and g Ã . Equation (17) shows that the upper bound on the number of false positives is inversely proportional to z ts .
For the ith gene, stability selection strategy assign each factor (i.e., genes, DNA methylation sites and copy number variation) a weight score, reflecting their degrees of significance. For the association between the ith gene and jth factor, the association score S j i is defined by the proportion of the cases where the jth factor is selected to the total number of randomly selected subsamples.
Evaluation Criteria
We compare our method BMNPGRN with three methods DCGRN, ARACNE and CLR. In order to strictly evaluate a method on its performance as balanced by true positive rates (TPR) and false positive rates (FPR), we use receiver operating characteristic (ROC) curve, area under receiver operating characteristic (AUROC) and area under precision recall curve (AUPRC), which are calculated based on confusion matrix (Fig. 2) .
where true positive (TP), false positive (FP), true negative (TN), and false negative (FN) are defined in Fig. 2 
RESULTS
In this section, we first compared the performance of BMNPGRN with three state-of-the-art methods (including DCGRN, ARACNE and CLR) in two kinds of synthetic datasets. DCGRN is a method using LASSO with DNA methylation site and CNV [22] , ARACNE is an algorithm for reverse engineering of gene regulatory network [30] . CLR is a context likelihood relatedness-based gene regulatory network inference algorithm [31] . We then applied BMNPGRN on breast cancer data from TCGA and identified several significant gene regulatory networks.
Performance Comparison on Synthetic Datasets
In this section, the BMNPGRN algorithm was tested in terms of different aspects, and the section is organized as follows. First, in order to demonstrate the superiority of BMNPGRN over three state-of-the-art methods (including DCGRN, ARACNE and CLR) in naive synthetic dataset used by three state-of-the-art methods, a naive experiment is designed to compare BMNPGRN with three methods.
Second, the performance of the BMNPGRN algorithm is compared with three methods (i.e., DCGRN, ARACNE and CLR) in a more practical synthetic dataset which contains relevant factors (i.e., associated genes and associated DNA methylation sites).
Naive Synthetic Datasets
In this section, we compare the performance of the BMNPGRN with three methods (including DCGRN, ARA-CNE and CLR) in naive synthetic dataset used by three state-of-the-art methods. In this kind of dataset, it is assumed that the ith gene is only affected by DNA methylation site which belong to the ith gene, and biological factors are independent of each other. First we introduce this naive synthetic random networks. We followed the synthetic dataset generation method of [22] . P represents the number of genes and is set to 30, 40, and 50. P Â P matrix F is initialized to zero matrix, then elements of F are randomly selected avoiding any cycle. The parameter E G represents the number of inbound edges per gene on average. The larger the parameter E G , the more complex the network. The weight value f ij is uniformly distributed over ½0:5; 1 or ½À0:5; 1. Meanwhile, the adjacency matrix G and W are initialized to zero matrix, then diagonal elements (g ii and w ii ) are randomly selected. The parameter R DC represents the percentage of nodes that are regulated by DNA methylation sites and copy number variation. For example, if P and R DC are 30 and 0.2 respectively, then it means six (30 Â 0:2) DNA methylation sites and copy number variations regulate corresponding genes (i.e., six diagonal elements of G and W are non-zero). The selected weight value g ii is uniformly distributed over ½0:5; 1 or ½À0:5; 1, and selected w ii is set to 1. d ij from uniform distribution U½0; 1. c ij is randomly set as -2, -1, 0, 1, or 2 with the probabilities 0.01, 0.22, 0.55, 0.2 and 0.02 respectively. The design gene expression matrix X can be generated by calculating X ¼ ðDG þ CW þ EÞðF À IÞ À1 , where each element of E is generated from zero-mean Gaussian distribution.
Performance Evaluaition on Naive Synthetic Datasets
We compare our method BMNPGRN with three methods DCGRN, ARACNE and CLR. Given data X, D and C,F,Ĝ andŴ are inferred, and then they are compared to the true edges of F, G and W, and calculating TPR and FPR. For the naive synthetic dataset, we generated two sets of datasets based on different parameter combinations. The parameters of first set of naive synthetic datasets (FNSD) are: N 2 f100; 200; 300; 400g, E G ¼ 1, R DC ¼ 0:3 and P ¼ 30. 
Complex Synthetic Datasets
In this section, we compare our method BMNPGRN with three methods DCGRN, ARACNE and CLR in a complex synthetic datasets. C, W, E, F and I are initialized in the same way as in naive synthetic dataset. We describe how to 
. For BMNPGRN, we show the results with two settings for z ts 0.6, 0.8 and two penalty functions.
generate D and G, next. First, we randomly selected K DNA methylation sites which located in core sequences of gene promoters and transcription start sites (TSS). Second, generating K groups based on these K DNA methylation sites. The number of DNA methylation sites in group is randomly selected from 2, 3, and 4. Third, we used popular value-based co-correlation network method to generate co-correlation expression vectors of D [12] . The correlation coefficient is calculated by the Pearson correlation formula. It should be noted that the sample contains both patient and normal samples. Based on this information, co-correlation networks were constructed. Finally, d ij from uniform distribution U½0; 1. The diagonal elements of G are 0. The selected weight value g ij is uniformly distributed over ½0:5; 1 or ½À0:5; 1.
For the complex synthetic dataset, we generated two sets of datasets based on different parameter combinations. The parameters of first set of complex synthetic datasets (FCSD) are: N 2 f100; 200; 300; 400g, E G ¼ 2, R DC ¼ 0:3 and P ¼ 30. Tables S3 and S4 , available online respectively. Experimental results show that BMNPGRN outperforms other methods in naive synthetic dataset.
Performance Evaluation of Bmnpgrn and Bmnpgrn without Stability Selection
In order to verify the effect of the stability selection strategy [29] , we generated one set of datasets based on different parameter combinations. The parameters of third set of complex synthetic datasets (TCSD) are: N 2 f100; 200; 300; 400g, E G ¼ 3, R DC ¼ 0:4, and P ¼ 30. This dataset is used to compare the performance of BMNPGRN and BMNPGRN without stability selection. The ROC comparison results of the datasets are shown in Fig. 7 .
Application to Breast Cancer Data
Breast cancer is the most common malignancy in United States women, accounting for >40,000 deaths each year. Discovering cancer-related biological pathway information is one of the key challenges of breast cancer research. Identifying comprehensive gene regulatory network can provide an important resource for studying the underlying mechanisms of breast cancer.
We applied BMNPGRN to a dataset, containing measurement profiles of gene expression, DNA methylation, and copy number variation. Gene expression profiles was measured experimentally using the Illumina HiSeq 2000 RNA Sequencing platform, downloaded from TCGA. DNA methylation profiles were obtained from the ratios of background-corrected methylated and un-methylated probe intensities measured by Illumina Infinium HumanMethylation450k BeadArrays, also downloaded from TCGA. The 
. For BMNPGRN, we show the results with two settings for z ts 0.6, 0.8 and two penalty functions. gene-level CNVs estimated using the GISTIC2 method. There are 760 case and 80 control samples measured from breast tissue. There are 24776 genes and corresponding CNVs in gene expression data and copy number variation data. There are 485578 DNA methylation sites in data. Fig. 8 is the integrated network with 14 genes that have high absolute value of coefficient. There are two DNA methylation sites that are connected to gene KCNK12. Also, there is a CNV that is connected to the gene SLC2A3. Several studies have been reported KCNK12 is associated with breast cancer but there is no report about associations with DNA methylation sites of the gene KCNK12 [37] , [38] , [39] . Several studies have been reported IPO8 is associated with breast cancer but there is no report about associations with DNA methylation sites of the gene IPO8 [40] , [41] . It should be noted that CNP11949 is first discovered related to breast cancer [42] , [43] . Several studies have been reported BRCA1 and TP53 are associated with breast cancer [44] . Experimental results provide genes that need attention in future work. TNF and CTNNB1 play an important role in gene regulatory network.
CONCLUSIONS
In this paper, we propose an approach, which use biweight midcorrelation to measure the correlation between factors and make use of Nonconvex Penalty based sparse regression for Gene Regulatory Network inference (BMNPGRN). BMNPGRN incorporates multi-omics data (including DNA methylation and copy number variation) and their interactions in gene regulatory network model. The experimental results on synthetic datasets show that BMNPGRN outperforms popular and state-of-the-art methods (including DCGRN, ARACNE and CLR) under false positive control. Furthermore, we applied BMNPGRN on breast cancer (BRCA) data from The Cancer Genome Atlas database and provided gene regulatory network.
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